Endocrinology, Vol 137, 3265-3273, Copyright © 1996 by Endocrine Society

ARTICLES

Retinoids increase cell-cell adhesion strength, beta-catenin protein stability, and localization to the cell membrane in a breast cancer cell line: a role for serine kinase activity

S Byers, M Pishvaian, C Crockett, C Peer, A Tozeren, M Sporn, M Anzano and R Lechleider
Department of Cell Biology, Georgetown University Medical Center, Washington D.C.20007, USA.

In this study we show that a breast cancer cell line (SKBR3) that expresses no E-cadherin and very low levels of beta-catenin protein and exhibits a poorly adhesive phenotype in Matrigel responds to retinoic acid (RA) by a marked increase in epithelial differentiation. Specifically, treatment of cells with all-trans-RA, 9-cis-RA, or a RA receptor alpha-specific ligand resulted in a large increase in cell- cell adhesive strength and stimulated the formation of fused cell aggregates in Matrigel. A retinoid X receptor-specific ligand was ineffective. Exposure of cells to 9-cis-RA for as little as 4 h was sufficient to maintain the adhesive phenotype for at least 4 days. The effects of 9-cis-RA required protein and RNA synthesis, but were not mediated by factors secreted by stimulated cells or by direct cell contact and did not require serum. These 9-cis-RA-induced morphological effects were completely reversed by growing cells in 50 microM Ca2+, suggesting a mechanism involving a 9-cis-RA-induced increase in Ca(2+)- dependent adhesion. Consistent with this, beta-catenin protein levels were markedly elevated in the 9-cis-RA-treated cells, and beta-catenin became localized to a Triton-insoluble pool at regions of cell-cell contact. No change could be detected in beta-catenin steady state messenger RNA levels, but 9-cis-RA did increase beta-catenin protein stability. Treatment of cells with low calcium medium did not prevent the 9-cis-RA-induced increase in total beta-catenin protein, but did prevent its movement to a Triton-insoluble pool at the cell membrane. Among several kinase inhibitors, only the broad spectrum kinase inhibitor staurosporine and the protein kinase C inhibitor bisindoylmaleimide reversed the morphological changes induced by 9-cis- RA. Like treatment with low calcium medium, these inhibitors did not prevent the 9-cis-RA-induced increase in total beta-catenin protein levels, but completely prevented the movement of beta-catenin to the cell membrane. These results point to a role for beta-catenin and serine kinase activity in mediating the action of 9-cis-RA in epithelial differentiation.

This article has been cited by other articles:

				A. Hozawa, D. R. Jacobs Jr., M. W. Steffes, M. D. Gross, L. M. Steffen, and D.-H. Lee Relationships of Circulating Carotenoid Concentrations with Several Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) Study Clin. Chem., March 1, 2007; 53(3): 447 - 455. [Abstract] [Full Text] [PDF]

				Y. L. Pon and A. S. T. Wong Gonadotropin-Induced Apoptosis in Human Ovarian Surface Epithelial Cells Is Associated with Cyclooxygenase-2 Up-Regulation via the {beta}-Catenin/T-Cell Factor Signaling Pathway Mol. Endocrinol., December 1, 2006; 20(12): 3336 - 3350. [Abstract] [Full Text] [PDF]

				D. J. Mulholland, S. Dedhar, G. A. Coetzee, and C. C. Nelson Interaction of Nuclear Receptors with the Wnt/{beta}-Catenin/Tcf Signaling Axis: Wnt You Like to Know? Endocr. Rev., December 1, 2005; 26(7): 898 - 915. [Abstract] [Full Text] [PDF]

				J. J. Otero, W. Fu, L. Kan, A. E. Cuadra, and J. A. Kessler {beta}-Catenin signaling is required for neural differentiation of embryonic stem cells Development, August 1, 2004; 131(15): 3545 - 3557. [Abstract] [Full Text] [PDF]

				H. E. Weitzel, M. R. Illies, C. A. Byrum, R. Xu, A. H. Wikramanayake, and C. A. Ettensohn Differential stability of {beta}-catenin along the animal-vegetal axis of the sea urchin embryo mediated by dishevelled Development, June 15, 2004; 131(12): 2947 - 2956. [Abstract] [Full Text] [PDF]

				D. A. Swartz-Basile, L. Wang, Y. Tang, H. A. Pitt, D. C. Rubin, and M. S. Levin Vitamin A deficiency inhibits intestinal adaptation by modulating apoptosis, proliferation, and enterocyte migration Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G424 - G432. [Abstract] [Full Text] [PDF]

				L.-N. Song, R. Herrell, S. Byers, S. Shah, E. M. Wilson, and E. P. Gelmann {beta}-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent Transcription Mol. Cell. Biol., March 1, 2003; 23(5): 1674 - 1687. [Abstract] [Full Text] [PDF]

				S. Shah, M. J. Pishvaian, V. Easwaran, P. H. Brown, and S. W. Byers The Role of Cadherin, beta -Catenin, and AP-1 in Retinoid-regulated Carcinoma Cell Differentiation and Proliferation J. Biol. Chem., July 5, 2002; 277(28): 25313 - 25322. [Abstract] [Full Text] [PDF]

				H. You, W. Yu, B. G. Sanders, and K. Kline RRR-{alpha}-Tocopheryl Succinate Induces MDA-MB-435 and MCF-7 Human Breast Cancer Cells to Undergo Differentiation Cell Growth Differ., September 1, 2001; 12(9): 471 - 480. [Abstract] [Full Text] [PDF]

				K. Fukunaka, T. Saito, K. Wataba, K. Ashihara, E. Ito, and R. Kudo Changes in expression and subcellular localization of nuclear retinoic acid receptors in human endometrial epithelium during the menstrual cycle Mol. Hum. Reprod., May 1, 2001; 7(5): 437 - 446. [Abstract] [Full Text] [PDF]

				E. Pötter, C. Bergwitz, and G. Brabant The Cadherin-Catenin System: Implications for Growth and Differentiation of Endocrine Tissues Endocr. Rev., April 1, 1999; 20(2): 207 - 239. [Abstract] [Full Text]

				K. Orford, C. Crockett, J. P. Jensen, A. M. Weissman, and S. W. Byers Serine Phosphorylation-regulated Ubiquitination and Degradation of beta -Catenin J. Biol. Chem., October 3, 1997; 272(40): 24735 - 24738. [Abstract] [Full Text] [PDF]

				J R Miller and R T Moon Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes & Dev., October 15, 1996; 10(20): 2527 - 2539. [PDF]